Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Transcriptome Analysis Identifies LINC00152 as a Biomarker of Early Relapse and Mortality in Acute Lymphoblastic Leukemia

13 Mar 2020

Abstract excerpt

Evidence showing the role of long non-coding RNAs (lncRNAs) in leukemogenesis have emerged in the last decade. It has been proposed that these genes can be used as diagnosis and/or prognosis biomarkers in childhood acute lymphoblastic leukemia (ALL). To know if lncRNAs are associated with early relapse and early mortality, a microarray-based gene expression analysis in children with B-lineage ALL (B-ALL) was...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer-related molecular mechanisms research
Share to Mycobacterium research and diagnosis
Share to RNA modifications and cancer

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 32183133
DOI: 10.3390/genes11030302

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Transcriptome Analysis Identifies LINC00152 as a Biomarker of Early Relapse and Mortality in Acute Lymphoblastic LeukemiaPMID 32183133Read ↗

LncRNAs serve as novel biomarkers for diagnosis and prognosis of childhood ALLSemantic proximity Read ↗

Identification of novel lncRNAs involved in the pathogenesis of childhood acute lymphoblastic leukemiaSemantic proximity Read ↗

Differential mRNA and Long Noncoding RNA Expression Profiles in Pediatric B-Cell Acute Lymphoblastic Leukemia Patients by BioinformaticsSemantic proximity Read ↗

Gene expression classifiers for relapse-free survival and minimal residual disease improve risk classification and outcome prediction in pediatric B-precursor acute lymphoblastic leukemiaSemantic proximity Read ↗

Differential mRNA and Long Noncoding RNA Expression Profiles in Pediatric B-Cell Acute Lymphoblastic Leukemia PatientsSemantic proximity Read ↗

A three‑lncRNA signature for prognosis prediction of acute myeloid leukemia in patientsSemantic proximity Read ↗

Gene expression–based classification and regulatory networks of pediatric acute lymphoblastic leukemiaSemantic proximity Read ↗

Refining risk prediction in pediatric acute lymphoblastic leukemia through DNA methylation profilingSemantic proximity Read ↗

Gene-based outcome prediction in multiple cohorts of pediatric T-cell acute lymphoblastic leukemia: a Children's Oncology Group studySemantic proximity Read ↗

LINC00649 underexpression is an adverse prognostic marker in acute myeloid leukemiaSemantic proximity Read ↗

A distinct set of long non-coding RNAs in childhood MLL-rearranged acute lymphoblastic leukemia: biology and epigenetic targetSemantic proximity Read ↗

Biologic pathways associated with relapse in childhood acute lymphoblastic leukemia: a Children's Oncology Group studySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.